219 related articles for article (PubMed ID: 36919172)
1. Can corporate social responsibility protect firm value during the COVID-19 pandemic?
Qiu SC; Jiang J; Liu X; Chen MH; Yuan X
Int J Hosp Manag; 2021 Feb; 93():102759. PubMed ID: 36919172
[TBL] [Abstract][Full Text] [Related]
2. How does social responsibility investment strategy contribute to hospitality firms' recovery from public health emergencies? The case of COVID-19 pandemic.
Wu D; Li H; Yang J
Int J Hosp Manag; 2023 Aug; 113():103530. PubMed ID: 37292494
[TBL] [Abstract][Full Text] [Related]
3. The Impact of COVID-19 on the Stock Price of Socially Responsible Enterprises: An Empirical Study in Taiwan Stock Market.
Lee KJ; Lu SL
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546396
[TBL] [Abstract][Full Text] [Related]
4. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
Tian J; Wang X; Wei Y
Front Public Health; 2022; 10():956521. PubMed ID: 36052006
[TBL] [Abstract][Full Text] [Related]
5. The impact of hotel CSR for strategic philanthropy on booking behavior and hotel performance during the COVID-19 pandemic.
Shin H; Sharma A; Nicolau JL; Kang J
Tour Manag; 2021 Aug; 85():104322. PubMed ID: 34815613
[TBL] [Abstract][Full Text] [Related]
6. Corporate immunity to the COVID-19 pandemic.
Ding W; Levine R; Lin C; Xie W
J financ econ; 2021 Aug; 141(2):802-830. PubMed ID: 34580557
[TBL] [Abstract][Full Text] [Related]
7. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
[TBL] [Abstract][Full Text] [Related]
8. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
Gao D; Zhao Y; Tian Q
Front Psychol; 2022; 13():950436. PubMed ID: 35911051
[TBL] [Abstract][Full Text] [Related]
9. Performance of socially responsible firms during the COVID-19 crisis and trading behavior by investor type: Evidence from the Korean stock market.
Lee S; Lee D; Hong C; Park MH
Financ Res Lett; 2022 Mar; 45():102660. PubMed ID: 35002551
[TBL] [Abstract][Full Text] [Related]
10. Do Employee Stock Ownership Plans Affect Corporate Social Responsibility? Evidence from China.
Zhou L; Wei F; Kong Y
Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162079
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Financial Redundancy on Corporate Social Responsibility Performance: Evidence From Chinese Listed Firms.
He L; Gan S; Zhong T
Front Psychol; 2022; 13():882731. PubMed ID: 35664182
[TBL] [Abstract][Full Text] [Related]
12. How Corporate Social Responsibility Boosts Corporate Financial and Non-financial Performance: The Moderating Role of Ethical Leadership.
Bouichou SI; Wang L; Zulfiqar S
Front Psychol; 2022; 13():871334. PubMed ID: 35693531
[TBL] [Abstract][Full Text] [Related]
13. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
Zhang Y; Yang F
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
[TBL] [Abstract][Full Text] [Related]
14. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
Zhong M; Zhao W; Shahab Y
Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
[TBL] [Abstract][Full Text] [Related]
15. The Impact of COVID-19 Pandemic on Corporate Social Responsibility and Job Embeddedness in China.
Meirun T; Lockey S; Blenkinsopp J; Yueyong H; Ling L
Front Psychol; 2022; 13():848902. PubMed ID: 35496231
[TBL] [Abstract][Full Text] [Related]
16. Corporate social responsibility and customer's responses: CSR authenticity and government intervention during the COVID-19 pandemic.
Balqiah TE; Astuti RD; Martdianty F; Hati SRH
Heliyon; 2023 May; 9(5):e15962. PubMed ID: 37220485
[TBL] [Abstract][Full Text] [Related]
17. Did Corporate Social Responsibility Vaccinate Corporations Against COVID-19?
Poursoleyman E; Mansourfar G; Hassan MK; Homayoun S
J Bus Ethics; 2023 Feb; ():1-27. PubMed ID: 36743218
[TBL] [Abstract][Full Text] [Related]
18. Corporate social responsibility, internal control, and firm financial performance.
Zhang L; Su W
Front Psychol; 2022; 13():977996. PubMed ID: 36660285
[TBL] [Abstract][Full Text] [Related]
19. Corporate social responsibility and firm performance nexus: Moderating role of CEO chair duality.
Nasir W; Hassan A; Khan MH
PLoS One; 2023; 18(8):e0289037. PubMed ID: 37535598
[TBL] [Abstract][Full Text] [Related]
20. Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.
Droppert H; Bennett S
Global Health; 2015 Apr; 11():15. PubMed ID: 25886175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
